The Burrill Report

The Burrill Report (April 14, 2014): Personalizing Cancer Therapies with a Mouse (.MP3,17.69 Mb)

Treating cancer has long been a trial and error process for doctors, but Champions Oncology is hoping to take the guess work out of choosing the right therapy through the use of its mouse avatars. The company engrafts a patient’s tumor in mice to determine what drugs are most effective. We spoke to Joel Ackerman, CEO of Champions Oncology, about the personalization of cancer therapy, the benefits the mouse avatars provide, and how the same technology is being used to improve drug development.

April 10, 2014
http://www.burrillreport.com/article-personalizing_cancer_therapies_with_a_mouse.html